e-learning
resources
Paris 2018
Sunday, 16.09.2018
Management of bronchiectasis and large airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prophylactic azithromycin in patients with primary ciliary dyskinesia.
A. Massiot (Paris, France), A. Tamalet (Paris, France), N. Beydon (Paris, France), E. Escudier (Paris, France), A. Clement (Paris, France), H. Corvol (Paris, France), G. Thouvenin (Paris, France)
Source:
International Congress 2018 – Management of bronchiectasis and large airway diseases
Session:
Management of bronchiectasis and large airway diseases
Session type:
Thematic Poster
Number:
798
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Massiot (Paris, France), A. Tamalet (Paris, France), N. Beydon (Paris, France), E. Escudier (Paris, France), A. Clement (Paris, France), H. Corvol (Paris, France), G. Thouvenin (Paris, France). Prophylactic azithromycin in patients with primary ciliary dyskinesia.. 798
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Primary ciliary dyskinesia in patients with recurrent pulmonary symptoms
Source: Annual Congress 2004 - Chronic respiratory illness in childhood
Year: 2004
Are inhaled corticosteroids prescribed rationally in primary ciliary dyskinesia?
Source: Eur Respir J, 51 (3) 1702221; 10.1183/13993003.02221-2017
Year: 2018
Hypofertility in adult patients with primary ciliary dyskinesia
Source: International Congress 2017 – Paediatric bronchology in clinical practice
Year: 2017
Study of mucociliary fuction in patients with primary ciliary dyskinesia with its different courses
Source: Eur Respir J 2004; 24: Suppl. 48, 281s
Year: 2004
Primary ciliary dyskinesia: the patients grow up
Source: Eur Respir J 2016; 48: 297-300
Year: 2016
Vestibular function in adult patients with primary ciliary dyskinesia
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Nasal cavity inflammation in patients with primary ciliary dyskinesia (PCD) is associated with bacterial infection
Source: International Congress 2017 – Paediatric respiratory infections and immunity
Year: 2017
Management of primary ciliary dyskinesia in European children: recommendations and clinical practice
Source: Eur Respir J 2012; 39: 1482-1491
Year: 2012
Sleep study in primary ciliary dyskinesia patients
Source: Annual Congress 2010 - Adenotonsillectomy and paediatric sleep medicine
Year: 2010
Primary ciliary dyskinesia
Source: Breathe 2014; 10:122-133
Year: 2014
Primary ciliary dyskinesia
Source: International Congress 2018 – State of the art session: Paediatric respiratory diseases
Year: 2018
Evaluation of sleep quality in primary ciliary dyskinesia patients
Source: Annual Congress 2008 - Diagnostic paediatric lung function: technical and clinical aspects
Year: 2008
Treatments for primary ciliary dyskinesia (PCD) in children across Europe
Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases
Year: 2008
Clinical index to evaluate the risk of primary ciliary dyskinesia in children
Source: Annual Congress 2012 - Paediatric respiratory epidemiology: something for everyone!
Year: 2012
Bronchoscopic findings in children with primary ciliary dyskinesia: Most but not all patients have bacterial bronchitis
Source: Annual Congress 2012 - Paediatric bronchology
Year: 2012
Retrospective study of lung function in a group of patients with primary ciliary dyskinesia
Source: Eur Respir J 2001; 18: Suppl. 33, 296s
Year: 2001
Primary ciliary dyskinesia
Source: Eur Respir Mon 2011; 54: 201-217
Year: 2011
Standardised clinical data from patients with primary ciliary dyskinesia: FOLLOW-PCD
Source: ERJ Open Res, 6 (1) 00237-2019; 10.1183/23120541.00237-2019
Year: 2020
Is primary ciliary dyskinesia a "biofilm" disease?
Source: Annual Congress 2012 - New insights into respiratory infections in children
Year: 2012
Primary ciliary dyskinesia in the neonatal period
Source: Eur Respir Monogr 2021; 92: 118-132
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept